Clinical Overview
The Depression, Anxiety and Stress Scale-21 (DASS-21) is a 21-item self-report questionnaire developed by Lovibond and Lovibond to assess the severity of depression, anxiety, and stress symptoms in adults. This shortened version of the original 42-item DASS maintains the three-factor structure while providing efficient assessment across all three emotional states. The DASS-21 is designed to measure the negative emotional states of depression, anxiety, and stress over the past week using a 4-point severity scale ranging from “did not apply to me at all” to “applied to me very much or most of the time.” Unlike diagnostic instruments, the DASS-21 focuses on dimensional assessment of symptom severity rather than categorical diagnosis. Each subscale contains 7 items that assess specific symptom clusters: depression (dysphoria, hopelessness, devaluation of life, self-deprecation, lack of interest/involvement, anhedonia, and inertia), anxiety (autonomic arousal, situational anxiety, and subjective experience of anxious affect), and stress (difficulty relaxing, nervous arousal, agitation, irritability, and impatience).
Key Validation Points
- Strong Factor Structure – Confirmed three-factor structure (depression, anxiety, stress) with excellent model fit across diverse populations and cultural contexts
- Excellent Psychometric Properties – Demonstrated high internal consistency (Cronbach’s alpha > 0.85 for all subscales) and test-retest reliability
- Cross-Cultural Validation – Successfully validated in over 25 languages and cultural contexts with established measurement invariance
- Convergent and Discriminant Validity – Strong correlations with established measures of depression and anxiety while maintaining distinct subscale properties
- Clinical Utility Evidence – Proven effectiveness in clinical settings with established severity cut-off points for normal, mild, moderate, severe, and extremely severe levels
- Research Foundation – Extensively used in psychological research with over 3,000 peer-reviewed publications supporting its validity and clinical utility
Primary Use Cases
- Tripartite Symptom Assessment – Simultaneous evaluation of depression, anxiety, and stress symptoms within a single efficient instrument
- Clinical Screening and Monitoring – Comprehensive screening for multiple emotional states and monitoring treatment progress across symptom domains
- Research Applications – Validated outcome measure for studies examining depression, anxiety, stress, and their interrelationships
- Community Mental Health Screening – Population-based screening tool for identifying individuals with elevated psychological distress
- Treatment Outcome Evaluation – Assessment of therapeutic effectiveness across multiple emotional domains in integrated treatment approaches
Access This Scale
Choose an access option below to download the scale.
